Julia M. Nagle

1.4k total citations · 1 hit paper
6 papers, 843 citations indexed

About

Julia M. Nagle is a scholar working on Molecular Biology, Oncology and Economics and Econometrics. According to data from OpenAlex, Julia M. Nagle has authored 6 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Economics and Econometrics. Recurrent topics in Julia M. Nagle's work include Economic and Financial Impacts of Cancer (2 papers), Clinical practice guidelines implementation (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). Julia M. Nagle is often cited by papers focused on Economic and Financial Impacts of Cancer (2 papers), Clinical practice guidelines implementation (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). Julia M. Nagle collaborates with scholars based in United States, Switzerland and India. Julia M. Nagle's co-authors include Nabeel Bardeesy, Rushika M. Perera, Phillip D. Jones, Sally Kawano, Shiwei Han, X. Shawn Liu, James Chen, Dai-Chen Wu, Vikram Deshpande and Jürgen K. Willmann and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Julia M. Nagle

6 papers receiving 832 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stromal response to Hedgehog signaling restrains pancreatic cancer progression

2014 386 citations John J. Lee, Rushika M. Perera et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Julia M. Nagle

Since Specialization

Citations

This map shows the geographic impact of Julia M. Nagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia M. Nagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia M. Nagle more than expected).

Fields of papers citing papers by Julia M. Nagle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia M. Nagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia M. Nagle. The network helps show where Julia M. Nagle may publish in the future.

Co-authorship network of co-authors of Julia M. Nagle

This figure shows the co-authorship network connecting the top 25 collaborators of Julia M. Nagle. A scholar is included among the top collaborators of Julia M. Nagle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia M. Nagle. Julia M. Nagle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Cost and survival analysis before and after implementation of Dana-Farber Clinical Pathways for Patients with Stage IV Non-Small Cell Lung Cancer. 2017 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), Tom Nguyen, Julia M. Nagle, Christine Lydon, Michael S. Rabin, Kristen K. McNiff, Joseph O. Jacobson, David M. Jackman	21
2	Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non–Small-Cell Lung Cancer 2017 ·Journal of Oncology Practice ·David M. Jackman, (unknown), (unknown), Tom Nguyen, Julia M. Nagle, Christine Lydon, Michael S. Rabin, Kristen K. McNiff, (unknown), Joseph O. Jacobson	52
3	LKB1 loss links serine metabolism to DNA methylation and tumorigenesis 2016 ·Nature ·Filippos Kottakis, Brandon Nicolay, Ahlima Roumane, Rahul Karnik, Hongcang Gu, Julia M. Nagle, Myriam Boukhali, Michele C. Hayward, Yvonne Y. Li, Ting Chen, Marc Liesa, Peter S. Hammerman, Kwok‐Kin Wong, D. Neil Hayes, Orian S. Shirihai, Nicholas J. Dyson, Wilhelm Haas, Alexander Meissner, Nabeel Bardeesy	233
4	Stromal response to Hedgehog signaling restrains pancreatic cancer progression breakdown → 2014 ·Proceedings of the National Academy of Sciences ·John J. Lee, Rushika M. Perera, Huaijun Wang, Dai-Chen Wu, X. Shawn Liu, Shiwei Han, Julien Fitamant, Phillip D. Jones, Krishna S. Ghanta, Sally Kawano, Julia M. Nagle, Vikram Deshpande, Yves Boucher, (unknown), James Chen, Jürgen K. Willmann, Nabeel Bardeesy, Philip A. Beachy	386
5	Coordination of DNA repair by NEIL1 and PARP-1: a possible link to aging 2012 ·Aging ·Nicole Noren Hooten, (unknown), (unknown), Kimberly D. Jacob, (unknown), Julia M. Nagle, Janice Barnes, Althaf Lohani, Michele K. Evans	37
6	An equilibrium-dependent retroviral mRNA switch regulates translational recoding 2011 ·Nature ·Brian Houck‐Loomis, Michael A. Durney, Carolina Salguero, (unknown), Julia M. Nagle, Stephen P. Goff, Victoria D′Souza	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact